verapamil has been researched along with Airway Hyper-Responsiveness in 4 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present studies the protective effect of the calcium-antagonist drug verapamil against allergen-induced asthma was assessed in eight atopic patients." | 7.66 | Effect of verapamil on allergen-induced asthma in patients with respiratory allergy. ( Bianchini, C; Cottini, M; Leggieri, E; Miadonna, A; Restuccia, M; Tedeschi, A, 1983) |
| " In the present studies the protective effect of the calcium-antagonist drug verapamil against allergen-induced asthma was assessed in eight atopic patients." | 3.66 | Effect of verapamil on allergen-induced asthma in patients with respiratory allergy. ( Bianchini, C; Cottini, M; Leggieri, E; Miadonna, A; Restuccia, M; Tedeschi, A, 1983) |
| " These results suggest that verapamil, at the dosage used, did not prevent allergic bronchoconstriction by a direct action on smooth muscle and therefore was effective by inhibiting the release of mast cell mediators." | 1.27 | Modification of allergic bronchoconstriction by a calcium antagonist: mode of action. ( Abraham, WM; Ahmed, T; Marchette, B; Russi, EW; Yerger, L, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Russi, EW | 1 |
| Marchette, B | 1 |
| Yerger, L | 1 |
| Abraham, WM | 1 |
| Ahmed, T | 2 |
| Miadonna, A | 1 |
| Tedeschi, A | 1 |
| Leggieri, E | 1 |
| Cottini, M | 1 |
| Restuccia, M | 1 |
| Bianchini, C | 1 |
| Chand, N | 1 |
| Diamantis, W | 1 |
| Sofia, RD | 1 |
| Russi, E | 1 |
| Kim, CS | 1 |
| Danta, I | 1 |
4 other studies available for verapamil and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
Modification of allergic bronchoconstriction by a calcium antagonist: mode of action.
Topics: Airway Resistance; Animals; Antigens; Ascaris; Bronchi; Bronchial Spasm; Carbachol; Histamine Antago | 1983 |
Effect of verapamil on allergen-induced asthma in patients with respiratory allergy.
Topics: Administration, Oral; Adult; Aerosols; Allergens; Asthma; Basophils; Bronchial Provocation Tests; Cy | 1983 |
The obligatory role of calcium in the development of antigen-induced airway hyperreactivity to cold provocation in the rat isolated trachea.
Topics: Animals; Antigens; Calcium; Cold Temperature; In Vitro Techniques; Male; Muscle Contraction; Ovalbum | 1987 |
Comparative effects of oral and inhaled verapamil on antigen-induced bronchoconstriction.
Topics: Administration, Oral; Adult; Airway Resistance; Asthma; Bronchi; Bronchial Provocation Tests; Constr | 1985 |